Capricor Therapeutics, Inc.
CAPR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133869
No open-market purchases or sales by Capricor Therapeutics, Inc. insiders were filed in the last 90 days; 169 institutions reported holding it in 13F filings for Q2 2026, worth $941.6M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Capricor Therapeutics, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 132 | 4 | 177 | +49 |
| Shares | 27.4M | 2.96M | 33.8M | +9.37M (+38.3%) |
| Value | $790.7M | $85.5M | $1.03B | +$322.2M (+45.7%) |
4 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (71)
Institutions that held Capricor Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
Sold out (22)
Institutions that held Capricor Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Darwin Global Management, Ltd. | 800,000 | $23.2M |
| Soleus Capital Management, L.P. | 646,390 | $18.7M |
| National Bank of Canada | 143,500 | $4.14M |
| Adage Capital Partners GP, L.L.C. | 130,000 | $3.75M |
| Ameriprise Financial Inc | 125,169 | $3.61M |
| Superstring Capital Management LP | 96,334 | $2.78M |
| Fred Alger Management, LLC | 80,793 | $2.33M |
| Anson Funds Management LP | 68,018 | $1.96M |
| Simplex Trading, LLC | 55,707 | $1.61M |
| Jump Financial, LLC | 49,500 | $1.43M |
| Creek Drive Management Group LLC | 36,000 | $1.04M |
| Quest Partners LLC | 30,056 | $867.4K |
| Jain Global LLC | 21,700 | $626.3K |
| Acadian Asset Management LLC | 20,100 | $579.0K |
| Susquehanna Portfolio Strategies, LLC | 13,295 | $383.7K |
| Nomura Holdings Inc | 9,876 | $285.0K |
| ProShare Advisors LLC | 7,033 | $203.0K |
| Parkside Financial Bank & Trust | 5,020 | $144.9K |
| Amalgamated Bank | 1,209 | $35.0K |
| Aster Capital Management (DIFC) Ltd | 526 | $15.2K |
| SageView Advisory Group, LLC | 20 | $578 |
| Bare Financial Services, Inc | 17 | $491 |
Not filed for Q1 2026 yet (4)
Institutions that held Capricor Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 2,561,880 | $73.9M |
| SB Capital Management Inc | 400,001 | $11.5M |
| DV Equities, LLC | 100 | $2.89K |
| New Millennium Group LLC | 11 | $317 |